Send to a Friend Font Size: Increase Decrease

AXSM and AZN Related Headlines

Nov 6, 2025 07:02AM Axsome Therapeutics acquires epilepsy drug candidate from AstraZeneca
Nov 6, 2025 07:00AM Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy

AXSM and AZN Related Press Releases

Nov 6, 2025 07:00AM Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy

AXSM and AZN Related SEC Filings